INVO Fertility shares surge 22.49% after-hours after announcing $4M at-the-market private placement with institutional investor.

INVO Fertility surged 22.49% in after-hours trading following the announcement of a $4.0 million private placement priced at $1.69 per share, including warrants to purchase up to 4.73 million additional shares. The offering, led by Maxim Group LLC, is expected to close on December 3, 2025, and will fund the company’s expansion of fertility clinics and INVOcell technology distribution. The transaction, structured as a Nasdaq at-the-market deal, signals institutional confidence in the company’s growth strategy. A concurrent but unconfirmed plan to acquire Family Beginnings, a fertility clinic in Indiana, further reinforced positive sentiment, though details remain undisclosed. The move contrasts with a prior 16% intraday decline, suggesting renewed investor optimism about capital access and strategic expansion.